- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- How specialty practices can get more out of technology investments
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
The NIH's rate change notice capping indirect costs on research grants has brought out the lunatics in academe. American Prospect is demanding that President Trump follow the science funding policies of Adolf Hitler. The author, Robert Kuttner is co-founder and co-editor of The American Prospect, and a professor at Brandeis University’s Heller School for Social Policy and Management in Waltham, Massachusetts. Somehow, Dr. Kuttner fails to mentions Hitler's most notable medical/scientific innovations, Aktion T4 and Organization Wirths in their Konzentrationslager:
https://prospect.org/politics/2025-02-10-what-trump-could-learn-from-hitler-on-nih-funding/
What Trump Could Learn From Hitler on NIH Funding
Even the Führer knew to support German science, and not just for war. Why is Trump trying to destroy America’s great research universities?By Robert Kuttner - February 10, 2025
On Friday, the National Institutes of Health announced that it is capping the amount of overhead on all research grants to 15 percent. Overhead pays for everything from the cost of research labs to the expense of applying for grants to administrator salaries to the cost of filing patent applications.
The average overhead has been running at about 26 percent, and at some top research universities such as Harvard, Yale, and Johns Hopkins, it is over 60 percent. The administration also plans to cut funding for the National Science Foundation by at least two-thirds.
NIH and NSF are a big part of why the U.S. is the world’s leader in science and technology. In 2023, NIH distributed about $35 billion through about 50,000 grants to over 300,000 researchers. Nine billion of this was overhead. Shrinking overhead will reduce these universities’ ability to conduct research.
Why is Trump doing this? Is this assault on NIH the war against the deep state on autopilot? Something very similar was in the Project 2025 blueprint. Is Trump trying to punish big research universities in blue states? Is it simple nihilism?
One source of Trump’s wreckage of state support for science and technology is Elon Musk. When Musk and his small team of engineers working in a garage were inventing the first private space rocket, they found they could do it a lot more cheaply than NASA, which was hidebound by elaborate rules and specifications that added needless costs.
Just two years after Musk launched his first successful rocket into orbit in 2008, it was Barack Obama who ordered NASA to contract out rocket launches to Musk to save costs. For Musk, the takeaway was that science and technology doesn’t need government.
But of course, it is government via NASA that ultimately pays for SpaceX. And biotech research is a whole other story from rocketry. It can’t be done in a garage; it requires labs, teams of researchers, and careful clinical trials.
NIH and NSF grants aren’t the deep state. The money doesn’t stay in Washington; it goes out to finance research. And a lot of major research universities are in red or purple states.
Heather Cox Richardson reported that eight Florida research universities will lose $165 million. Six in Ohio will lose $194 million; and four in Missouri will lose $212 million. And that doesn’t count the cost of future lost grants that universities will lack the capacity to apply for.
It’s one thing to trash USAID. In the view Trump and Musk have tried to cement with the public, the benefits go to a bunch of foreigners, often in shithole countries, sometimes to promote DEI. (This of course is total BS. USAID mainly alleviates starvation and disease, and prevents China from dominating the Global South.)
But it’s something else to destroy the world-class institutions that make America great, to coin a phrase. Even Hitler did not trash German science.
Hitler did seek to turn science to his own ends, to promote research on eugenics, new technologies for blitzkrieg war, sick medical experiments, and more efficient ways for the mass killing of Jews. Yet civilian German science, long a mark of German pride, also thrived. During the Nazi era, German scientists and engineers invented the first electron microscope, industrial-scale production of artificial fiber, pharmaceuticals such as advanced sulfa drugs, artificial rubber, and much more.
Trump, in short, is even more nihilist than Hitler.
WE AWAIT THE PUSHBACK. Surely university leaders as well as governors and private-sector research clients in red states are already in touch with their legislative representatives in Washington. Are Republican House and Senate members so thoroughly intimidated by Trump that they won’t push back? We’ll soon find out.
When OMB issued its first lunatic order pausing virtually all federal grants-in-aid, even before the illegal move was enjoined by two federal judges, OMB began walking the order back. This was mainly because of massive pushback from red states. It would be surprising if something similar did not happen with the NIH order. Already, Republican Alabama Sen. Katie Britt is vowing to work to restore NIH funding to the universities in her home state.
As for NSF, its funding will be part of the coming battle over budget reconciliation. Of all the things that Republican legislators will give up in the negotiations, it’s hard to imagine them going to the mat with Democrats in order to cripple NSF.
As law professor Sam Bagenstos has reported, the NIH order is also probably illegal. In 2017, during Trump’s first administration when an assault on NIH was rumored, Congress attached a rider to the NIH appropriation requiring that NIH must not deviate from the formulas for indirect costs that were applied in the third quarter of FY2017.
As Bagenstos points out, the memo implementing the new policy also violates the Administrative Procedure Act, which requires a rulemaking and notice and comment for such a drastic change. Once again, there will be litigation and we will find out whether we can rely on the courts.
My informed hunch is that the 15 percent rule will be walked back first. Small-d democratic politics, battered but unbroken, to the rescue.
BMW 7 Series luxury sedans have a sick hold on our truly undistinguished academic culture. They will do anything, other than quality research, to live the luxe life.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















